Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
SorLA Blocking Peptide (AC1264)
Cat.#: ACPP-1264
Specifications
Despition SorLA Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1143 Recombinant Human Adenosine Receptor A2a Protein (Fc Tag) (AC1143) 50 µg inquiry ACPP-1613 Human RAB3IL1 Protein (AC1613) 2 µg inquiry ACPP-1496 Human SPINT2 Protein (AC1496) 2 µg inquiry ACPP-1119 CD56 Blocking Peptide (AC1119) 250 µg inquiry ACPP-1830 Human SDC1 Protein (AC1830) 5 µg inquiry ACPP-1732 Human CHRNA6 Protein (AC1732) 5 µg inquiry ACPP-1166 Recombinant Human VCAM1 Protein (Fc Tag) (AC1166) 50 µg inquiry ACPP-1827 Human NHLH2 Protein (AC1827) 2 µg inquiry ACPP-1660 Mouse GDF7 Protein (AC1660) 2 µg inquiry ACPP-1832 Human CRYZ Protein (AC1832) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket